The new formulation included BeadTek, which is an indistinguishable mix of inactive beads, active immediate-release hydrocodone beads, and active extended-release hydrocodone beads. The inactive beads remain inert and dissolve independently of the active hydrocodone beads. The inactive beads are designed not to change the 12-hour release properties of the medication when taken as directed, but will immediately form a viscous gel when crushed and dissolved in liquids or solvents.
Zohydro ER with BeadTek is a Schedule II opioid agonist indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment (eg, non-opioid analgesics or immediate-release opioids) are inadequate.
Zohydro ER capsules with BeadTek are available in 10mg, 15mg, 20mg, 30mg, 40mg, and 50mg strengths.
For more information visit ZohydroER.com.